Company Overview
Rhythm is a global, commercial-stage biopharmaceutical company committed to transforming the care of people living with rare melanocortin-4 receptor (MC4R) pathway diseases. Working at Rhythm means that you are part of a team that’s passionate about transforming the lives of people living with hyperphagia (pathological, insatiable hunger) and severe obesity caused by rare MC4R pathway diseases. We recognize the courage it takes for patients and their caregivers to begin their journey of advocacy to find the answers they need. Their courage inspires us to challenge convention, ask bold questions and seek answers for them. Every day, we strive for excellence through our willingness to adapt, learn, and our tenacity to overcome barriers, together.
Opportunity Overview
As Director of FP&A for the International Region, you will participate to the full implementation and growth of the International Region in a very dynamic and multicultural environment. You will thrive in this role if you are someone who has extensive experience working in an international setting, wants to make substantial contribution to a rapidly growing company, and is willing to be a trusted business partner and a key person in our International Finance organization.
The role will be based in the Netherlands in our Amsterdam office and reports directly to the VP, Head of International Region Finance and Commercial Operations.
Responsibilities and Duties
Budgeting & Forecasting:
Management Reporting:
Finance Special Projects:
Qualifications and Skills
This role is based in our International HQ office in Amsterdam, NL. Rhythm operates in a hybrid-work model. Candidates applying must be willing and able to have presence in the office in coordination with their department and business needs. This role may involve some travel.
Rhythm is a biopharmaceutical company aimed at developing and commercializing therapies for the treatment of rare genetic disorders of obesity. The company is targeting the melanocortin-4 receptor (MC4R) pathway that is impaired due to genetic variants. This is a key biological pathway that regulates weight and hunger. A central element of Rhythm’s mission is to improve the understanding of these disorders and develop management strategies for patients who have no treatment options available to them. Rhythm was founded in 2008 and is based in Boston, MA. The company’s clinical development program is currently focused on several rare genetic disorders of obesity, all driven by genetic variants in the MC4R pathway. For healthcare professionals, visit https://path4hcps.com/ for more information.
Read Full Description